These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Enzymatic Resistance of Corneas Crosslinked Using Riboflavin in Conjunction With Low Energy, High Energy, and Pulsed UVA Irradiation Modes. Aldahlawi NH; Hayes S; O'Brart DP; Akhbanbetova A; Littlechild SL; Meek KM Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1547-52. PubMed ID: 27046119 [TBL] [Abstract][Full Text] [Related]
9. Effect of Riboflavin Solution With Hydroxypropyl Methylcellulose and Eyelid Speculum on Pachymetry Changes During Accelerated Collagen Crosslinking. Akkaya Turhan S; Aydin FO; Toker E Cornea; 2019 Jul; 38(7):864-867. PubMed ID: 31170104 [TBL] [Abstract][Full Text] [Related]
10. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Wollensak G; Wilsch M; Spoerl E; Seiler T Cornea; 2004 Jul; 23(5):503-7. PubMed ID: 15220736 [TBL] [Abstract][Full Text] [Related]
11. Correlation Between Multimodal Microscopy, Tissue Morphology, and Enzymatic Resistance in Riboflavin-UVA Cross-Linked Human Corneas. Laggner M; Pollreisz A; Schmidinger G; Byrne RA; Scheinecker C; Schmidt-Erfurth U; Chen YT Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3584-92. PubMed ID: 26047045 [TBL] [Abstract][Full Text] [Related]
12. Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc. Vasilikos I; Teixeira GQ; Seitz A; Nothelfer J; Haas J; Wilke HJ; Mizaikoff B; Beck J; Hubbe U; Neidlinger-Wilke C PLoS One; 2021; 16(6):e0252672. PubMed ID: 34081754 [TBL] [Abstract][Full Text] [Related]
13. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro. Wollensak G; Spoerl E; Reber F; Seiler T Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922 [TBL] [Abstract][Full Text] [Related]
14. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A (UVA). Wollensak G; Iomdina E Acta Ophthalmol; 2009 Mar; 87(2):193-8. PubMed ID: 18803623 [TBL] [Abstract][Full Text] [Related]
15. Increased resistance of crosslinked cornea against enzymatic digestion. Spoerl E; Wollensak G; Seiler T Curr Eye Res; 2004 Jul; 29(1):35-40. PubMed ID: 15370365 [TBL] [Abstract][Full Text] [Related]
16. High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea. Zhu Y; Reinach PS; Zhu H; Tan Q; Zheng Q; Qu J; Chen W PLoS One; 2017; 12(6):e0179580. PubMed ID: 28644862 [TBL] [Abstract][Full Text] [Related]
17. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure. Krueger RR; Herekar S; Spoerl E Eye Contact Lens; 2014 Nov; 40(6):353-7. PubMed ID: 25365552 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive real-time assessment of riboflavin consumption in standard and accelerated corneal crosslinking. Lombardo M; Lombardo G J Cataract Refract Surg; 2019 Jan; 45(1):80-86. PubMed ID: 30360937 [TBL] [Abstract][Full Text] [Related]
19. Corneal thickness changes during corneal collagen cross-linking with UV-A irradiation and hypo-osmolar riboflavin in thin corneas. Nassaralla BA; Vieira DM; Machado ML; Figueiredo MN; Nassaralla JJ Arq Bras Oftalmol; 2013; 76(3):155-8. PubMed ID: 23929075 [TBL] [Abstract][Full Text] [Related]
20. UVA-photoactivated riboflavin effect on isolated vaginal tissues derived from pelvic organ prolapse cases. McMillan KS; Siddighi S; Hardesty JS; Yune JJ; Chan PJ Int Urol Nephrol; 2015 Jan; 47(1):75-9. PubMed ID: 25218617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]